CONGRESS 2013

  • 08:50 - 09:20 State of the art lecture

    Chairman:

    Tarik ASSELAH (France)
  • Targets for HCV therapy: clinical applications - Charles RICE (USA)
  • 10:20 Round table discussion
  • 10:40 - 11:00 Coffee break
  • 11:00 - 12:30 How to optimize current therapy of non G1 patients

    Chairs :

    Mark THURSZ (UK) Jake LIANG (USA)
  • 11:45 Round table discussion
  • 15:15 Round table discussion
  • 15:40 - 16:00 Coffee break
  • 17:00 Round table discussion
  • 17:20 - 17:50 Controversy: F1/F2 patients: treat or wait?

    Chairman:

    Graham FOSTER (UK)
  • 18:00 Ajournement
  • 19:30 Congress dinner

  • 09:25 Round table discussion
  • 10:00 - 10:30 Coffee break
  • 11:00 Round table discussion
  • 12:00 Round table discussion
  • 15:15 Round table discussion
  • 16:15 Round table discussion
  • 16:45 Ajournement